1. Home
  2. FATE vs PFL Comparison

FATE vs PFL Comparison

Compare FATE & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • PFL
  • Stock Information
  • Founded
  • FATE 2007
  • PFL 2003
  • Country
  • FATE United States
  • PFL United States
  • Employees
  • FATE N/A
  • PFL N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • PFL Finance Companies
  • Sector
  • FATE Health Care
  • PFL Finance
  • Exchange
  • FATE Nasdaq
  • PFL Nasdaq
  • Market Cap
  • FATE 142.4M
  • PFL 329.9M
  • IPO Year
  • FATE 2013
  • PFL N/A
  • Fundamental
  • Price
  • FATE $1.27
  • PFL $8.50
  • Analyst Decision
  • FATE Hold
  • PFL
  • Analyst Count
  • FATE 10
  • PFL 0
  • Target Price
  • FATE $6.75
  • PFL N/A
  • AVG Volume (30 Days)
  • FATE 1.2M
  • PFL 113.7K
  • Earning Date
  • FATE 02-24-2025
  • PFL 01-01-0001
  • Dividend Yield
  • FATE N/A
  • PFL 11.53%
  • EPS Growth
  • FATE N/A
  • PFL N/A
  • EPS
  • FATE N/A
  • PFL N/A
  • Revenue
  • FATE $13,447,000.00
  • PFL N/A
  • Revenue This Year
  • FATE N/A
  • PFL N/A
  • Revenue Next Year
  • FATE N/A
  • PFL N/A
  • P/E Ratio
  • FATE N/A
  • PFL N/A
  • Revenue Growth
  • FATE N/A
  • PFL N/A
  • 52 Week Low
  • FATE $1.04
  • PFL $6.98
  • 52 Week High
  • FATE $8.83
  • PFL $8.62
  • Technical
  • Relative Strength Index (RSI)
  • FATE 40.64
  • PFL 53.56
  • Support Level
  • FATE $1.21
  • PFL $8.45
  • Resistance Level
  • FATE $1.49
  • PFL $8.60
  • Average True Range (ATR)
  • FATE 0.10
  • PFL 0.05
  • MACD
  • FATE 0.02
  • PFL 0.01
  • Stochastic Oscillator
  • FATE 31.25
  • PFL 54.55

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: